Trial Profile

A multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy of combined opioid and naldemedine treatment for preventing opioid-induced constipation (OIC) in cancer patients with cancer pain

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 16 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Jul 2024 New trial record
04 Jun 2024 Primary endpoint has been met (Percentage of patients with a Bowel Function Index of less than 28.8 on Day 14) , according to Results presented at the 60th Annual Meeting of the American Society of Clinical Oncology
04 Jun 2024 Results from phase III portion of this trial presented at the 60th Annual Meeting of the American Society of Clinical Oncology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com